Haemonetics Corporation (HAE) has a market capitalization of $2.83B and trades at $60.48. The 52-week range is 47.32-87.32.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 18.3, Earnings Per Share (EPS) of $3.31, annual revenue of $1.36B.
The stock has a beta of 0.36, operates in the Healthcare sector.
